TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
IDYA

Ideaya Biosciences Inc

Healthcare · Biotechnology

36.70$ -1.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow IDYA
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – 283.9% -199.6% -171.2% -492.7% -3,536.9% -32.5%
– – – 7.1% 6.2% 4.1% 17.1% 54.8% 2.1%
– – – 18.5% 29.5% 22.8% 79.1% 496.4% 21.1%
– – – 21.3% 29.5% 22.8% – – –
– – – 432.0% -63.8% -81.6% -56.5% 164.9% 0.9%
– – – 2.5% 9.5% 6.8% 10.1% 55.1% 1.1%
– – – -748.5% -249.3% -65.6% -677.6% -7,179.4% 32.0%
– – – 6.1% 315.6% 173.4% – – –
– – – 659.0% 520.6% 190.8% 1,551.1% 9,679.3% 13.6%
– – – 194.3% 71.6% -46.0% 380.7% -1,037.0% 13.0%
– – – 281.3% -209.1% -177.9% -502.9% -3,592.0% -33.6%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?